Related references
Note: Only part of the references are listed.Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance
Christopher H. Crane et al.
CANCER (2016)
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis
Randa Tao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S. Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Multimodality treatment of intrahepatic cholangiocarcinoma: A review
Kerri A. Simo et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery
Tomoaki Yoh et al.
WORLD JOURNAL OF SURGERY (2016)
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Edgar Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases
Shin Hwang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
HER2/neu-directed therapy for biliary tract cancer
Milind Javle et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Outcomes following resection of intrahepatic cholangiocarcinoma
Parissa Tabrizian et al.
HPB (2015)
Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma A Multi-institutional Analysis of 535 Patients
Gaya Spolverato et al.
JAMA SURGERY (2015)
Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma
Yasuhito Arai et al.
HEPATOLOGY (2014)
Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients
Junichi Shindoh et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
Surgical Resection after Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer: A Retrospective Single-center Study
Atsushi Kato et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Causes of Death in Patients With Hepatitis B: A Natural History Cohort Study in the United States
Jean-Luc Szpakowski et al.
HEPATOLOGY (2013)
Rebleeding Prophylaxis Improves Outcomes in Patients With Hepatocellular Carcinoma: A Multicenter Case-Control Study
Cristina Ripoll et al.
HEPATOLOGY (2013)
Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma A Multi-institutional Analysis of 434 Patients
Dario Ribero et al.
ARCHIVES OF SURGERY (2012)
Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Single-Center Study
Sang Myung Woo et al.
CHEMOTHERAPY (2012)
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Anne M. Horgan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
AJCC 7th Edition of TNM Staging Accurately Discriminates Outcomes of Patients With Resectable Intrahepatic Cholangiocarcinoma
Olivier Farges et al.
CANCER (2011)
Intra-hepatic cholangiocarcinoma-frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center
Ashwani K. Singal et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Intrahepatic Cholangiocarcinoma: New Insights in Pathology
Christine Sempoux et al.
SEMINARS IN LIVER DISEASE (2011)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in-patients undergoing major hepatectomy: Analysis of 1,557 consecutive liver resections
Martin Palavecino et al.
SURGERY (2010)
The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival
Sae-Byeol Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Intrahepatic cholangiocardnoma - Rising frequency, improved survival, and determinants of outcome after resection
Itaru Endo et al.
ANNALS OF SURGERY (2008)
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
Boris Blechacz et al.
HEPATOLOGY (2008)
RADIATION THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN THE ADJUVANT AND DEFINITIVE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA
Eric T. Shinohara et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment
M. Michele Manos et al.
HEPATOLOGY (2008)
Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection
TA Aloia et al.
ANNALS OF SURGERY (2005)
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
YH Shaib et al.
JOURNAL OF HEPATOLOGY (2004)
Share Paper
